NASDAQ:ALGN - Nasdaq - US0162551016 - Common Stock - Currency: USD
182.58
-2.26 (-1.22%)
The current stock price of ALGN is 182.58 USD. In the past month the price increased by 5.01%. In the past year, price decreased by -28.57%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 28.88 | 44.01B | ||
COO | COOPER COS INC/THE | 21.62 | 16.30B | ||
SOLV | SOLVENTUM CORP | 12.55 | 12.92B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 27.68 | 5.84B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.61 | 5.26B | ||
BLCO | BAUSCH + LOMB CORP | 24.48 | 4.15B | ||
HAE | HAEMONETICS CORP/MASS | 15.08 | 3.46B | ||
XRAY | DENTSPLY SIRONA INC | 9.95 | 3.33B | ||
ICUI | ICU MEDICAL INC | 19.33 | 3.32B | ||
UFPT | UFP TECHNOLOGIES INC | 29.29 | 1.84B | ||
NEOG | NEOGEN CORP | 16.32 | 1.35B | ||
ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.09B |
Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,945 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
ALIGN TECHNOLOGY INC
410 North Scottsdale Road, Suite 1300
Tempe ARIZONA 95134 US
CEO: Joseph M. Hogan
Employees: 20945
Phone: 14084701000
The current stock price of ALGN is 182.58 USD. The price decreased by -1.22% in the last trading session.
The exchange symbol of ALIGN TECHNOLOGY INC is ALGN and it is listed on the Nasdaq exchange.
ALGN stock is listed on the Nasdaq exchange.
24 analysts have analysed ALGN and the average price target is 233.62 USD. This implies a price increase of 27.95% is expected in the next year compared to the current price of 182.58. Check the ALIGN TECHNOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALIGN TECHNOLOGY INC (ALGN) has a market capitalization of 13.37B USD. This makes ALGN a Large Cap stock.
ALIGN TECHNOLOGY INC (ALGN) currently has 20945 employees.
ALIGN TECHNOLOGY INC (ALGN) has a support level at 182.57 and a resistance level at 187.49. Check the full technical report for a detailed analysis of ALGN support and resistance levels.
The Revenue of ALIGN TECHNOLOGY INC (ALGN) is expected to grow by 3.6% in the next year. Check the estimates tab for more information on the ALGN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALGN does not pay a dividend.
ALIGN TECHNOLOGY INC (ALGN) will report earnings on 2025-07-30, after the market close.
The PE ratio for ALIGN TECHNOLOGY INC (ALGN) is 19.57. This is based on the reported non-GAAP earnings per share of 9.33 and the current share price of 182.58 USD. Check the full fundamental report for a full analysis of the valuation metrics for ALGN.
The outstanding short interest for ALIGN TECHNOLOGY INC (ALGN) is 4.67% of its float. Check the ownership tab for more information on the ALGN short interest.
ChartMill assigns a technical rating of 4 / 10 to ALGN. When comparing the yearly performance of all stocks, ALGN is a bad performer in the overall market: 78.63% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to ALGN. ALGN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months ALGN reported a non-GAAP Earnings per Share(EPS) of 9.33. The EPS increased by 4.6% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.54% | ||
ROA | 6.78% | ||
ROE | 10.94% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 76% to ALGN. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of 12.35% and a revenue growth 3.6% for ALGN